- Long-term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study
- Periprocedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant–treated patients
- Malignancy development risk in psoriatic arthritis patients undergoing treatment: A systematic review and meta-analysis
- What predicts falls in Parkinson disease? Observations from the Parkinson's Foundation registry
- Intraoperative radiotherapy in the era of intensive neoadjuvant chemotherapy and chemoradiotherapy for pancreatic adenocarcinoma
- Phase II study of everolimus and octreotide LAR in patients with nonfunctioning gastrointestinal neuroendocrine tumors: The GETNE1003_EVERLAR study
- A randomized, controlled phase I/II study to evaluate the safety and efficacy of MGV354 for ocular hypertension or glaucoma
- Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysis
- Association of opioid-related adverse drug events with clinical and cost outcomes among surgical patients in a large integrated health care delivery system
- Optimal doses of H1 antihistamines do not increase susceptibility to febrile convulsions in children
- Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status
- Acid?suppressive drugs and risk of kidney disease: A systematic review and meta?analysis
- Effects of clopidogrel with or without aspirin on the generation of extracellular vesicles in the microcirculation and in venous blood: A randomized placebo controlled trial
- Impact of insulin degludec in hospitalized patients with and without type 2 diabetes requiring parenteral/enteral nutrition: an observational study
- Pharmacokinetic and pharmacodynamic profile of the sodium?glucose co?transporter-2 inhibitor empagliflozin in young people with Type 2 diabetes: A randomized trial
Feed Sources
